NCT07879755Recruiting
An Extension Trial of GW 906 in Participants With Essential Hypertension
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of GW906 (SAL0132) Injection in Patients With Essential Hypertension
Source: ClinicalTrials.gov · Last updated 19 Oct 2026
Brief summary (registry, in English)
This clinical study was designed to assess the safety and efficacy of long-term dosing of GW906
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1500 (estimated)
- First submitted
- 18 Sept 2026
- Start date
- 12 Jun 2026
- Primary completion date
- 30 Jan 2029
- Lead sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Diseases
- High blood pressure
- NCT number
- NCT07879755
What you commit to
- Study type: Interventional
- Planned participants: 1500
- From 12 Jun 2026 to the primary completion date, 30 Jan 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Orthostatic hypotension accompanied by hypotension-related symptoms was observed in a prior study of GW906 injection.
Other illness
- Secondary hypertension.
- History of any cardiovascular event within 6 months.
- Patients with active malignancy or a history of malignancy.
Lab values
- Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \>2.5× upper limit of normal (ULN); Total bilirubin \> 1.5 × ULN; International normalized ratio (INR) \> 2.0; Serum potassium \> 5.0 mmol/L or \< 3.5 mmol/L; eGFR≤30 mL/min/1.73m\^2.
Who the study is looking for
- Completed study treatment and the study in accordance with the protocol for GW906 injection.
- Willing to participate in the study and provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai Jiao Tong University School of Medicine - Ruijin Hospital Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.